Aligos Therapeutics, Inc.

ALGS·NASDAQ·$8.72Share Price as of 11/2·$54MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/06/26 10-QQ1 ended 03/31/2605/07/26 10-KFY 202503/05/26 10-QQ3 ended 09/30/2511/06/25 10-QQ2 ended 06/30/2508/06/25

Disclosures

8-KCurrent report09/15/26 8-KCurrent report08/06/26 8-KCurrent report06/26/26 8-KCurrent report05/07/26 8-KCurrent report04/21/26

Prospectuses and Registrations

S-8Registration of securities for employees08/06/26 S-8Registration of securities for employees03/05/26 S-8Registration of securities for employees08/06/25 424B3Prospectus04/03/25 S-3Shelf registration03/27/25

Proxies

DEF 14ADefinitive proxy04/29/26 DEFA14AAdditional proxy materials04/29/26 DEF 14ADefinitive proxy04/28/25 DEFA14AAdditional proxy materials04/28/25 PRE 14APreliminary proxy04/16/25

Ownership

Form 4Insider transaction06/29/26 Form 4Insider transaction06/29/26 Form 4Insider transaction06/29/26 Form 4Insider transaction06/29/26 Form 4Insider transaction06/29/26

Other

ARSAnnual report to shareholders04/29/26 ARSAnnual report to shareholders04/28/25 EFFECTRequest for effectiveness04/03/25 CORRESPCorrespondence with the SEC04/01/25 UPLOADLetter from the SEC04/01/25